REFERENCES
  1. Sugaya K, Nishizawa O, Satoh T, Hatano T, Ogawa Y. Bladder-pumping therapy for the treatment of low-capacity or low-compliance bladders. Neurourol. Urodyn. 2000;19(1):19-28.
  2. Wu CQ, Franco I. Management of vesicoureteral reflux in neurogenic bladder. Investig Clin Urol. 2017;58(Suppl 1):S54-8.
  3. Arunachalam D, Heit M. Low Bladder Compliance in Women: A Clinical Overview. Female Pelvic Med Reconstr Surg. 2020;26(4):263-9.
4. Iglesia CB, Smithling KR. Pelvic organ prolapse. Am Fam Physician. 2017; 96(3):179–85.
5. Aichner S, Fähnle I, Frey J, Krebs J, Christmann-Schmid C. Impact of sacrocolpopexy for the management of pelvic organ prolapse on voiding dysfunction and roflowmetry parameters: a prospective cohort study. Arch Gynecol Obstet. 2022;306(4):1373-80.
6. Liao JY, Lin YH, Liang CC, Hsieh WC, Lee SJ, Tseng LH. Monitoring bladder compliance using end filling detrusor pressure: Clinical results and related factors. Taiwan J Obstet Gynecol. 2015;54(6):709-15.
7. Long CY, Hsu SC, Sun DJ, Chen CC, Tsai EM, Su JH. Abnormal clinical and urodynamic findings in women with severe genitourinary prolapse. Kaohsiung J Med Sci. 2002;18(12):593-7.
8. Majkusiak W, Horosz E, Tomasik P, Zwierzchowska A, Wielgoś M, Barcz E. Quality of life assessment in women after cervicosacropexy with polypropylene mesh for pelvic organ prolapse: a preliminary study. Menopausal Rev. 2015;14(2):126–9.
9. Luo DY, Yang TX, Shen H. Long term Follow-up of Transvaginal Anatomical Implant of Mesh in Pelvic organ prolapse. Sci Rep. 2018;8(1):2829.
10. US Food and Drug Administration. FDA news release: FDA strengthens requirement for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks. Silver Springs, MD: US Food and Drug Administration: January 4, 2016.
11. Rogowski A, Kluz T, Szafarowska M, Mierzejewski P, Sienkiewicz-Jarosz H, Samochowiec J, et al. Efficacy and safety of the Calistar and Elevate anterior vaginal mesh procedures. Eur J Obstet Gynecol Reprod Biol. 2019; 239:30–4.
12 Naumann G, Hüsch T, Mörgeli C, Kolterer A, Tunn R. Mesh-augmented transvaginal repair of recurrent or complex anterior pelvic organ prolapse in accordance with the SCENIHR opinion. Int Urogynecol J 2021;32:819–27.
13. Mateu-Arrom L, Gutiérrez-Ruiz C, Palou Redorta J, Errando-Smet C. Pelvic organ prolapse repair with mesh: Description of surgical technique using the Surelift®Anterior Repair System. Urol Int. 2021;105: 137–42.
14. Long CY, Hsu CS, Wu CH, Liu CM, Wang CL, Tsai EM. Three-year outcome of transvaginal mesh repair for the treatment of pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2012;161:105–8.
15. Peng HY, Lai CY, Hsieh MC, Lin TB. Solifenacin/mirabegron induces an acute compliance increase in the filling phase of the capacity-reduced urinary bladder: A pressure-volume analysis in rats. Front Pharmacol 2021;12:657959.
16. Lau HH, Lai CH, Peng HY, Hsieh MC, Su TH, Lee JJ, et al. Tension-free trans-obturator tape enhanced thermodynamic efficacy of the bladder in stress urinary incontinence patients: A retrograde observational study. Front Bioeng Biotechnol 2022;10:912602.
17. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. International Continence Society. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21: 261–74.
18. Peng HY, Lai CY, Hsieh MC, Ho YC, Lin TB. Pressure-volume analysis of rat’s micturition cycles in vivo. Neurourol Urodyn. 2020;39(5):1304-12.
19. Loo ZX, Chen HS, Tang FH, Lin KL, Liu YY, Wu MP, et al. Predictors of voiding dysfunction following Uphold™ mesh repair for the treatment of pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2020;255:34-9.
20. Ma Y, Kang J, Zhang Y, Ma C, Wang Y, Zhu L. Medium-term effects on voiding function after pelvic reconstructive surgery of advanced pelvic organ prolapse: Is postoperative uroflowmetry necessary? Eur J Obstet Gynecol Reprod Biol. 2021;258:447-51.
21. Mills IW, Drake MJ, Greenland JE, Nobel JG, Brading AF. The contribution of cholinergic detrusor excitation in a pig model of bladder hypocompliance. BJU Int. 2000;86(4):538-43.
22. Hsieh MF, Tsai HW, Liou WS, Lo CC, Lin ZH, An YF, et al. Long-term compliance of vaginal pessaries: Does stress urinary incontinence matter? Medicine (Baltimore). 2019;98(14):e15063.
23. Cameron AP, Clemens JQ, Latini JM, McSuire EJ. Combination drug therapy improves compliance of the neurogenic bladder. J Urol 2009; 182(3):1062-7.
24. Toppercer A, Tetreault JP. Compliance of the bladder: an attempt to establish normal values. Urology 1979;14(2):204–5.
25. Harris RL, Cundiff GW, Theofrastous JP, Bump RC. Bladder compliance in neurologically intact women. Neurourol Urodyn 1996;15(5):483–8.
26. Habteyes FG, Komari SO, Nagle AS, Klausner AP, Heise RL, Ratz PH, et al. Modeling the influence of acute changes in bladder elasticity on pressure and wall tension during filling. J Mech Behav Biomed Mater. 2017;71:192-200.
27. Bu L, Yang D, Nie F, Li Q, Wang YF. Correlation of the type and degree of cystocele with stress urinary incontinence by transperineal ultrasound. J Med Ultrason. 2020;47(1):123-30.
28. Kummeling MTM, Rietbergen JBW, Withagen MIJ, Mannaerts GHH, van der Weiden RMF. Sequential urodynamic assessment before and after laparoscopic sacrocolpopexy. Acta Obstet Gynecol Scand. 2013; 92(2):172–7.
29. Dörflinger A, Monga A. Voiding dysfunction. Curr Opin Obstet Gynecol. 2001;13(5):507–12.
30. Espuña Pons M, Cassadó J, Díez Itza I, Valero Fernández EM. Post-void residual and voiding dysfunction symptoms in women with pelvic organ prolapse before and after vaginal surgery. A multicenter cohort study. Actas Urol Esp (Engl Ed). 2021;45(1):57-63.
31. Lau HH, Su TH, Huang WC. Effect of aging on lower urinary tract symptoms and urodynamic parameters in women. Taiwan J Obstet Gynecol. 2021;60(3):513-6.
32. Bradley CS, Nygaard IE. Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol. 2005;106(4):759e66.
33. Romanzi LJ, Chaikin DC, Blaivas JG. The effect of genital prolapse on voiding. J Urol. 1999;161(2):581e6
34. McFadden E, Lay-Flurrie S, Koshiaris C, Richards GC, Heneghan C. The Long-Term Impact of Vaginal Surgical Mesh Devices in UK Primary Care: A Cohort Study in the Clinical Practice Research Datalink. Clin Epidemiol. 2021;13:1167-80.
35. Atis G, Arisan S, Ozagari A, Caskurlu T, Dalkilinc A, Ergenekon E. Tissue reaction of the rat urinary bladder to synthetic mesh materials. Sci World J 2009;9:1046-51.
36. Eslami MJ, Zargham M, Gholipour F, Hajian M, Bakhtiari K, Hajebrahimi S, et al. Transvaginal repair of anterior vaginal wall prolapse with polyvinylidene fluoride (PVDF) mesh: an alternative for previously restricted materials? Int Urogynecol J. 2022;33(7):1989-97.
37. Achtari C, Hiscock R, O’Reilly BA, Schierlitz L, Dwyer PL. Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:389–94.
38. Chughtai B, Mao J, Matheny ME, Mauer E, Banerjee S, Sedrakyan A. Long-Term Safety with Sling Mesh Implants for Stress Incontinence. J Urol. 2021;205(1):183-90.